Mit Ihrer Erlaubnis verwenden wir datenschutzfreundliche Analysen, um zu verstehen, welche Recherchewege funktionieren. Wir verwenden weder Werbe-Tracker noch Sitzungsaufzeichnungen. Sie können diese Auswahl in den Einstellungen ändern. Lesen Sie die Datenschutzerklärung.
Quote this valuation with its source: Fair value, Potential value and the price at analysis.
FAQ
WTW — frequently asked questions
Is Willis Towers Watson Public Limited Company overvalued?
In our latest published analysis dated 2026-10-05, WTW looks meaningfully undervalued. The price recorded at analysis is 289 USD versus our fair value of 427 USD; the high endpoint is presented separately as potential value of 650 USD. That implies roughly 48.1% upside to fair value at that date.
Our latest published report, analyzed 2026-10-05, gives WTW a fair value of 427 USD and a potential value of 650 USD. The conclusion is triangulated across multiple valuation models and weighted by reliability for Willis Towers Watson Public Limited Company's archetype; it is a dated research output, not a live price.
Should I buy WTW now?
Our latest published rating for WTW, analyzed 2026-10-05, is Strong Buy. Willis Towers Watson Public Limited Company looks meaningfully undervalued at the analysis-date price of 289 USD versus fair value of 427 USD; potential value is 650 USD. This is research for educational purposes, not personalized investment advice.
What are the biggest risks for WTW?
The dedicated bear-case section in our report analyzed 2026-10-05 documents Willis Towers Watson Public Limited Company's material risks, evidence, thresholds, and thesis-invalidation conditions. Scenario-specific explanations remain in that section so the report does not repeat or decontextualize them elsewhere.
What is WTW's rating?
Our latest published rating for WTW, analyzed 2026-10-05, is Strong Buy, with a published moat assessment of 7.5/10 (Narrow). It reflects our fair value of 427 USD, the potential value of 650 USD, and the price recorded at analysis (289 USD).
Englische Quelle wird angezeigt, während wir übersetzen
Dieser Bericht wurde noch nicht übersetzt. Aktualisieren Sie in ein paar Minuten, sobald die Übersetzungswarteschlange aufgeholt hat.
§1 ZusammenfassungEN
30-Sekunden-AntwortStrong Buy
Preis im Verhältnis zum Wert
Kurs
$288.61
Fairer Wert
$427.31
Potenzialwert
$650.40
Stand
2026-10-02
Warum es funktionieren kann
Successful execution of the $625 million Propel transformation program to automate routine administrative tasks, freeing client-facing broker and consultant capacity to accelerate new business origination, drive operating margins from 23.48% in FY2025 toward management's 2028 target of approximately 30%, and expand annual free cash flow above $2.0 billion to accelerate share repurchases.
Was unsere Einschätzung ändern würde
Risk & Broking organic revenue growth slows below 1.5% YoY over a 12-month observation horizon,.
We assign a Strong Buy rating to Willis Towers Watson Public Limited Company with a Fair value of USD 427.31, representing 48.06% upside from the current share price of USD 288.61. The company's entrenched oligopoly position in corporate benefits consulting and commercial risk brokerage, coupled with internal operational margin expansion from the $625 million Propel transformation program and disciplined capital return of at least $1.0 billion in annual share repurchases, creates an exceptionally attractive risk-adjusted compounding profile.3,4
Key operational and cyclical risks center on softening commercial property and casualty pricing conditions across international markets outside North American casualty, which threatens ad valorem commission growth across Risk & Broking ($4.22 billion FY2025 revenue). Concurrently, the multi-year $625 million cash commitment to the Propel transformation creates transitional cash restructuring drag through FY2028 before net cost benefits fully accrue,,, while peers such as Arthur J. Gallagher exhibit faster near-term top-line expansion at 13% forward growth.
These cyclical and transitional headwinds are countered by durable structural advantages. WTW maintains an entrenched position alongside Aon and Gallagher in corporate benefits and commercial brokerage, underpinned by substantial institutional switching costs in retirement administration, health plan design, and specialized placement facilities like Gemini. In FY2025, Health, Wealth & Career generated $5.29 billion in revenue and $1.68 billion in operating income, while Risk & Broking produced $1.07 billion in operating income. Consolidated operations are insulated from regional regulatory or pricing shocks by balanced geographic exposure across the United States (47.3%), the United Kingdom (21.7%), and Rest of World (31.5%).4,7
The central operational catalyst is the Propel restructuring program, which directly addresses the core operational constraint on brokerage growth: client-facing producer capacity. By automating routine manual administration, Propel reallocates consultant hours toward high-value advisory and new client acquisition, establishing a clear operational mechanism to drive consolidated operating margins from 23.48% in FY2025 to 24.64% in FY2026, 25.99% in FY2027, and 27.52% in FY2028 toward management's long-term target of approximately 30%.4,6
Robust free cash flow generation ($1.55 billion in FY2025) supports management's capital return commitment of at least $1.0 billion in annual share repurchases. Consistent share repurchases reduce the 99.0 million share baseline and compound consensus diluted EPS from $16.26 in FY2025 to $19.86 in FY2026 and $22.85 in FY2027. At USD 288.61 as of October 2, 2026, the market significantly undervalues this multi-year margin expansion and per-share compounding, supporting our Fair value of USD 427.31.1,3,4,5,6
WTW trades at USD 288.61, representing a 32.46% discount to our compositeFair value of USD 427.31 and a forward P/E multiple of 17.42x, providing 48.06% implied upside as operational execution normalizes.3
The $625 million Propel investment directly tackles internal advisor capacity constraints by automating non-client clerical work, creating a clear runway to expand operating margins from 23.48% in FY2025 toward management's 2028 target of approximately 30%.4,6
Aggressive Capital Return Compounding Per-Share Metrics
With $1.55 billion of free cash flow generated in FY2025, management's commitment to repurchase at least $1.0 billion of shares annually steadily shrinks the 99.0 million diluted share base and accelerates consensus EPS growth from $16.26 in FY2025 to $22.85 by FY2027.1,3,4,5,6
Hausempfehlung
Strong Buy. Willis Towers Watson offers a 32.46% discount to its Fair value of USD 427.31, underpinned by resilient consulting cash flows, operational margin expansion under Propel toward 28.77%–30.00%, and substantial share repurchases.4
Unternehmensüberblick
Willis Towers Watson Public Limited Company is a leading global advisory, broking, and solutions company operating through two core reporting segments: Health, Wealth & Career (HWC) and Risk & Broking (R&B). The company partners with institutional sponsors and corporate clients worldwide to manage risk, optimize employee benefits, cultivate executive talent, and expand financial security across corporate workforces.
In FY2025, Health, Wealth & Career generated $5.29 billion in revenue and $1.68 billion in operating income, providing actuarial consulting, pension and retirement administration, corporate healthcare benefits design, and talent management solutions. Risk & Broking generated $4.22 billion in revenue and $1.07 billion in operating income, providing specialized commercial property and casualty brokerage, wholesale placement, digital underwriting facilities such as Gemini, and insurance consulting and technology.
The company maintains balanced global operations with FY2025 revenue distributed across the United States ($4.50 billion or 47.3%), the United Kingdom ($2.07 billion or 21.7%), and Rest of World ($3.00 billion or 31.5%), with total foreign revenue of $9.57 billion.
§2 BärenszenarioEN
Our stress test models simultaneous compounding headwinds across commercial insurance brokerage pricing, transformation program execution, and capital costs. If commercial property and casualty pricing deflation accelerates outside North American casualty, Risk & Broking revenue growth would drop below 1.5% YoY, depressing top-line expansion across the firm's $4.22B placement base. Concurrently, if the $625M Propel cash restructuring program encounters implementation delays, heavy restructuring cash outflows would depress free cash flow conversion through FY2028, while consolidated operating margins fail to expand past 24% from the FY2025 baseline of 23.48%. In this stagflationary environment, an upward revision in the cost of equity from 7.45% to 9.45% would compress multiples and test the valuation floor of USD 286.42.
Commercial P&C rate softening outside North America accelerates, pulling organic revenue growth below guided mid-single-digit levels.4
Propel IT automation implementation stalls while restructuring expenses persist, capping operating margin expansion and delaying operational savings.4
Macro discount rate expands under persistent high interest rates.
In the downside scenario, commercial P&C rate softening across international property lines compresses ad valorem brokerage commissions, while consulting wage inflation outpaces fee realizations. Restructuring outlays under Propel fail to unlock producer productivity, leaving operating margins suppressed and depressing free cash flow conversion through FY2028.
Wie diese These scheitern kann
Severe commercial P&C pricing softening and commission deflation across primary global brokerage lines
Lucy Clarke confirmed softening pricing conditions across all markets outside North American casualty. If commercial P&C pricing deteriorates further, ad valorem commissions across R&B ($4.22B FY2025 revenue) would fall sharply below management's mid-single digit growth guidance.4,7
FV impact
-8.3%
Revenue and EPS growth 5 points lower for five years
Trigger
Within 12 months
Frühwarnsignale zur Überwachung
Die fünf Entwicklungen, die unsere Anlagethese schwächen würden.
Willis Towers Watson possesses a Narrow economic moat supported by entrenched switching costs in its consulting operations and global placement scale in commercial insurance broking. The firm operates as one of three dominant global intermediaries alongside Aon and Gallagher, commanding critical scale in placing complex commercial risks and administering corporate health and pension plans. In FY2025, WTW generated $9,516M in revenue and $2,234M in operating income, demonstrating substantial earning power across diversified global markets.
The primary foundation of WTW's moat resides in Health, Wealth & Career, which contributed $5,291M or 55.6% of FY2025 revenue and $1,681M in operating income. Corporate benefits administration and actuarial consulting entail profound operational switching costs. Corporate clients face high migration friction, employee disruption, and data security risks when transferring pension management or health plan administration to a competitor. These high switching costs protect retention rates above 90% and support stable recurring advisory fees.
In Risk & Broking, which generated $4,222M in FY2025 revenue and $1,072M in operating income, WTW's scale enables proprietary market-making structures such as Gemini. Global risk placement across the US ($4,504M), UK ($2,065M), and Rest of World ($2,996M) creates distribution density that regional brokers cannot replicate. Furthermore, the $625M Propel restructuring investment is reinforcing this advantage by automating administrative overhead, expanding producer throughput, and driving operating margins toward 30%.
Ökonomischer Gewinn
Willis Towers Watson generates sustained economic profits, evidenced by a latest ROIC of 13.73% which comfortably exceeds its computed WACC of 6.90% and moderate cost of equity of 7.45%. Even after factoring in $625M in planned cash restructuring outlays for Propel, capital efficiency remains high due to an asset-light operating model requiring only $229M in annual CapEx against $9,516M in revenue.2,4,6
7.5/ 10
Narrow
Sources of advantage
01Switching Costs in Enterprise Benefits and Pension Administration — The Health, Wealth & Career segment generated $5,291M in FY2025 revenue (55.6% of total) and $1,681M in operating income. Deep enterprise software integration, actuarial valuation models, and employee benefit recordkeeping systems create substantial switching friction and administrative risk for corporate clients attempting to switch providers.Wide
02Broker Distribution Network and Global Placement Scale
Bekannte Bedrohungen für den Wettbewerbsvorteil
Bedrohung
Schweregrad
Zeitrahmen
Minderung
Aggressive broker talent recruitment by peer firms
medium
12-24 months
Management is deploying $625M in Propel cash to automate manual tasks and free advisor capacity for high-value client advisory, while leveraging competitive equity-based incentives and active onboarding pipelines.4
The highlighted cell is Fair value when every assumption sits at its base level ($427.31). Each row and column shows what Fair value becomes when one assumption moves.
Free cash flow to the firm stays positive in the first projected year at $1.8B after modeled reinvestment of $247.4M, with terminal value at 86.1% of enterprise value. A sudden drop in free cash flow is not projected unless capital spending relative to revenue, reinvestment, or gross margin resets materially.
Consolidated revenue growth tracks mid-single digits in FY2026 in line with management guidance, moderating over the forecast horizon toward long-term GDP growth.4
Consolidated adjusted operating margin expands steadily from FY2025 levels across the forecast horizon, approaching management's long-term margin target.4,6
Capital allocation maintains annual share repurchases in line with management's capital return commitment, steadily reducing diluted shares outstanding.4
The modal base case path reflects steady mid-single-digit organic growth supported by recurring corporate benefits administration in Health, Wealth & Career and balanced international commercial placement. The Propel restructuring program steadily scales operating margins over the transformation horizon, while disciplined annual share repurchases compound per-share cash flow, supporting the compositefair value midpoint.4,7
Revenue growth and operating margin expansion ahead of the house forecast path confirm that Propel automation is unlocking broker capacity faster than planned, solidifying the trajectory toward long-term margin targets.
Im Plan
Maintain Strong Buy; Maintain existing portfolio allocation, verify quarterly Propel cost-benefit disclosures, and track share repurchases against management's annual capital return commitment.
In-line results match management's full-year mid-single-digit organic revenue growthguidance and confirm steady execution of the Propel restructuring schedule.
Verfehlt
Downgrade the rating; Review segment organic growth in Risk & Broking, monitor advisor attrition metrics, and assess whether to trim position weight toward the lower end of the recommended range.
Auslöser: Consolidated organic revenue growth decelerating below mid-single digits or adjusted operating margin flat to contracting YoY
A revenue or margin miss caused by severe commercial P&C rate softening or Propel IT automation delays would challenge the speed of margin normalization, requiring a reassessment of near-term operating leverage.
Ergebnisqualität
Earnings quality is solid, underscored by robust cash flow generation. In FY2025, operating cash flow of $1,775M comfortably exceeded GAAP net income of $1,605M, delivering a high 96.3% free cash flow conversion rate ($1,546M FCF). Diluted shares outstanding stood at 99.0M with reported GAAP EPS of $16.26. Over the FY2026-FY2028 transformation period, investors must monitor non-GAAP adjustments as $625M in Propel restructuring outlays flow through GAAP expenses,.4,5
Dynamik der Schätzungen
Consensus estimate momentum has been positive following the Q2 2026 earnings release. FY2026 consensus EPS rose by 1.76% from $19.50 to $19.85, and FY2027 consensus EPS increased by 3.11% from $22.17 to $22.86. Correspondingly, FY2026 consensus revenue rose to $10,490M and FY2027 consensus revenue increased to $11,026M, demonstrating upward analyst revisions.1
Wichtige Kennzahlen vor dem Bericht
01
Kennzahl:
Propel Transformation Progress and Reinvestment Run-Rate
AktuellImplementation underway with peak expenses scheduled across FY2026-FY2028,.
Warum es wichtig ist
The $625M cash restructuring program is the core driver of operating margin expansion toward the ~30% target by FY2028.4
02
Kennzahl:
Risk & Broking Organic Growth and Pricing Resilience
Aktuell
§8 Finanzielle Historie
Gewinn- und Verlustrechnung — letzte sechs Perioden
WTW's cash generation demonstrates high conversion efficiency characteristic of an established insurance intermediary. In FY2025, operating cash flow was $1,775M and capital expenditures were $229M, yielding free cash flow of $1,546M. During FY2026-FY2028, cash flow faces transitional headwinds as $625M in cash is deployed to fund Propel automation,. However, CFO Krasner confirmed that full-year free cash flow margins will expand even during Propel funding, followed by a significant step-up in free cash flow conversion once restructuring expenses subside post-2028.4,5,6
Kapitalallokation
Capital allocation is anchored by shareholder returns and targeted internal technology reinvestment. Total debt stands at $7,101M against a market capitalization of $26,804M, resulting in a moderate debt weight of 20.94% and pre-tax of 5.78%. Management prioritizes share repurchases, targeting at least $1.0B in repurchases for full year 2026, supported by $450M completed in Q2 2026. The regular dividend consumes approximately $3.84 per share annually, while remains disciplined at approximately 2.4% of ,.
Capital returns are projected to strengthen further over the forecast horizon. As the $625M Propel restructuring investment drives enterprise adjusted operating margins from 23.48% in FY2025 toward the ~30% FY2028 objective and 28.77% by FY2030, operating profit expansion on an asset-light capital base will steadily compound economic profit generation.
WTW's latest ROIC of 13.73% exceeds its computed WACC of 6.90% by 683 basis points, and surpasses its moderate cost of equity of 7.45% by 628 basis points.
Consolidated operating income reached $2,234M in FY2025 on $9,516M in revenue (23.48% margin),. Management is investing $625M in cash into Propel targeting adjusted of approximately 30% by 2028.
Jüngster Umsatz9,5 Mrd. $Umsatz-CAGR +2,1 %
Betriebsmarge23,5 %10 Geschäftsjahresperioden
Jüngster freier Cashflow1,5 Mrd. $FY2025
Nettoverschuldung6,5 Mrd. $FY2025
Aufschlüsselung der Gewinn- und VerlustrechnungWie sich die Unternehmensgröße in ausgewiesenen Gewinn übersetzt.
Willis Towers Watson Public Limited Company (WTW) trades at 17.4x forward earnings against a peer median of 14.3x. Its EV/EBITDA of 11.5x compares with a peer median of 13.6x. The comparison uses 4 peers: Aon plc, Erie Indemnity Company, Arthur J. Gallagher & Co. and M&T Bank Corporation, as of 2026-10-05.
§10 Branche & ZyklusEN
Zyklusphase
Expansion
The commercial insurance brokerage industry operates with low physical capital intensity, reflected in an industry capex-to-revenue ratio of 0.55% and capex-to-depreciation of 0.24. WTW's FY2025 capital expenditures of $229M relative to $9,516M in revenue illustrate that capital cycle spending is focused primarily on IT architecture, digital placement tools, and operational restructuring under the $625M Propel program.4,6
Bullenzyklus
A bull cycle in commercial insurance broking is characterized by rising property and casualty insurance premium rates ('hard market'), surging corporate healthcare inflation, and complex regulatory mandates. Rising premium rates mechanically increase ad valorem brokerage commissions, while regulatory changes drive corporate demand for specialized actuarial and benefits advisory services. Intermediaries benefit from operating leverage as revenues outpace administrative wage growth.
Bärenzyklus
A bear cycle is defined by commercial insurance pricing deflation ('soft market') across major property and specialty lines, combined with advisor wage inflation and corporate budget tightening. In this phase, ad valorem placement commissions contract as noted in international markets outside North American casualty, while corporate restructuring and headcount reductions soften benefits consulting project fees.
Säkulare Trends
Trend
Auswirkung
Hinweis
Corporate Benefits Complexity and Healthcare Cost Inflation
positive
Persistent inflation in healthcare costs and shifting pension regulations compel multinational corporations to seek specialized actuarial consulting and benefits administration, driving steady mid-single-digit organic growth in Health, Wealth & Career, which generated $5,291M in FY2025 revenue.
Algorithmic Placement and Digital Broker Facilities
positive
Positionierung
WTW holds an entrenched position within the global insurance broking and human capital consulting oligopoly. Its tripartite geographic footprint spanning the United States ($4,504M or 47.3%), the United Kingdom ($2,065M or 21.7%), and Rest of World ($2,996M or 31.5%) insulates consolidated earnings from regional pricing shocks. Furthermore, the $625M Propel restructuring program specifically targets internal supply constraints by automating clerical tasks and freeing broker hours for high-value client advisory. Because carrier lead times and customer concentration data are not separately disclosed by underwriting carriers, the industry cycle view is demand-led and evidence-limited.4,7
§11 PositionsmanagementEN
Positionsgröße
4-6%
The committee's Strong Buy rating and 48.06% implied upside to our compositefair value of USD 427.31 support a high-conviction overweight allocation. High recurring revenue from enterprise benefits administration ($5.29B FY2025 revenue) and an asset-light cash generation model provide downside stability, justifying a 4-6% position weight within institutional equity portfolios.7
Risiko
Position risk is managed through strict sizing limits (capped at 6% of total equity assets) and portfolio diversification. Downside volatility is dampened by WTW's balanced tripartite geographic revenue footprint (47.3% US, 21.7% UK, 31.5% Rest of World),, and recurring institutional revenues in Health, Wealth & Career ($5,291M FY2025 revenue). Continuous monitoring of quarterly checkpoints ensures disciplined risk mitigation if restructuring execution stalls or commercial rate deflation broadens.
Einstiegstranchen
Niveau
Aktion
Warum
USD 285.00 - USD 295.00
Deploy initial 50% tranche
Initiates core position at USD 288.61 as of October 2, 2026, capturing a 32.46% discount to compositefair value.
Adjusted operating margin <24.0% in FY2026 or failing to expand by at least 50 bps YoY
§12 Investoren-PerspektivenEN
Long-Term Fundamental Investor
Buy
WTW offers an exceptional risk-adjusted total return profile, trading at a 32.46% discount to our Fair value of USD 427.31. The combination of oligopoly positioning across corporate pensions and benefits administration ($5.29B FY2025 revenue) and operational leverage under the $625 million Propel plan supports sustained double-digit EPS compounding from $16.26 in FY2025 to $22.85 in FY2027.1,4,6,7
Income & Quality Compounder
Buy
The company's asset-light business model produces substantial free cash flow ($1.55B in FY2025), which funds both a stable dividend and aggressive share repurchases of at least $1.0 billion annually. With narrow-moat switching costs protecting client relationships, capital returns provide reliable downside support while share count shrinks from 99.0 million shares.3,4,5
Turnaround & Catalyst-Oriented Investor
Buy
Propel represents a clear internal operational catalyst to eliminate administrative bottlenecks and lift operating margins from 23.48% in FY2025 toward management's 2028 target of ~30%. Trading at an attractive forward P/E of 17.42x, multiple expansion alongside margin delivery offers substantial upside toward Fair value.3,4,6
§14 Endgültige EmpfehlungEN
Aktion
Starker Kauf
Willis Towers Watson Public Limited Company is rated Strong Buy with a Fair value of USD 427.31, providing 48.06% upside from the current share price of USD 288.61. The company's entrenched market position in institutional benefits consulting and commercial risk brokerage provides durable, recurring cash flows that are deeply undervalued by the market.3
While investors must monitor commercial P&C pricing softening outside North American casualty and transitional cash drag from the $625 million Propel program, the combination of operational margin expansion toward 28.77%–30.00% and at least $1.0 billion in annual share buybacks provides an outstanding risk-adjusted compounding profile.
§15Your notes
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
Private notes
Visible only to you. Synced to this device.
0 chars
Sources
The records this analysis drew on, as they stood when it was run.
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
Propel automation execution failure and restructuring cost inflation
Management committed $625M of cash to the Propel transformation to expand margins toward 30%. Restructuring outlays flow heavily through FY2026-FY2028 financials before savings accrue,. If IT automation implementation stalls while advisory compensation costs escalate, operating margins will fail to expand past 24% from FY2025 baseline of 23.48%.4,6
FV impact
-4.3%
Operating margin 3 points lower throughout
Trigger
Within 24 months
Macro valuation rerating and discount rate expansion under persistent high interest rates
House models currently discount equity claims at Ke moderate of 7.45% using a low adjusted beta of 0.5334 despite Damodaran sector peer beta of 0.6720 and a risk-free rate of 5.24%. An upward repricing of equity cost of capital by 200 bps compresses equity valuations across forward_earnings, multi_stage_moat_fade, and owner_earnings.2
Implementation friction or cost inflation within the $625M Propel restructuring program delays operating leverage, capping margins below the ~30% FY2028 objective.
Aktuell:23.48% in FY2025
Alarm, wennBelow 24.0% by FY2027
03
Advisor talent retention and attrition rate
Aggressive producer poaching by peer brokers such as AJG (compounding forward revenue at 13%) risks client account losses and drives up defensive retention compensation expenses.
Aktuell:Performing at or above expectations with strong H1 2026 hiring classes
Alarm, wennBroker and consultant attrition exceeding historical baseline by more than 300 basis points
Widespread commercial insurance pricing softening across international markets outside North American casualty and adverse foreign exchange movements impairing non-US revenue growth, undermining geographic diversification benefits.
Aktuell:Non-US revenue of $5,061M in FY2025 ($2,065M UK and $2,996M Rest of World)
Alarm, wennBelow 1.0% YoY in FY2026-FY2027
05
Annual capital return via share repurchases
Restructuring cash burn under the $625M Propel program or free cash flow compression forcing management to curtail share buybacks, slowing net share count reduction from the 99.0M base.
Aktuell:Target of at least $1.0B in 2026 with $450M completed in Q2 2026
Alarm, wennAnnual repurchases below $750M without accretive M&A deployment
— The Risk & Broking segment delivered $4,222M in FY2025 revenue and $1,072M in operating income. Worldwide distribution scale across North America ($4,504M), the UK ($2,065M), and Rest of World ($2,996M) enables proprietary placement arrangements such as Gemini, which automates up to 16% of program risk.
Diversification into fee-based consulting in Health, Wealth & Career ($5.29B FY2025 revenue) and expansion into resilient niches like North American casualty.4,7
68,4%
Method
Project EPS through the explicit advantage period, fade growth as competition catches up, and discount the full stream at cost of equity.
Discounted forecast-period cash flows (99,19 $) plus discounted terminal value (612 $) minus signed per current share (70,20 $) equals the 641 $ lens value shown above. Negative net debt is , so subtracting it raises value.
Propel automation achieves targeted efficiency ahead of schedule, lifting adjusted operating margins to 30.0% by FY2028.4
Annual capital returns exceed $1.0B in share repurchases, retiring 2.5% of common shares per year.4
Under the upside scenario, the $625M Propel restructuring program rapidly eliminates administrative bottlenecks, enabling brokers and consultants to win competitive market share from peers. Enterprise adjusted operating margins reach 30.0% by FY2028, supported by 35% in Health, Wealth & Career and 30% in Risk & Broking. Accelerated free cash flow expansion finances heavy share repurchases, compounding diluted EPS toward the top of our valuation range.4
Operating income is forecast to expand to $2,469M in FY2026 (24.64% margin) and $3,429M by FY2030 (28.77% margin), providing strong underlying operating leverage.
Asset-light model generates strong free cash flow conversion.
Management committed to capital return of at least $1.0B in 2026, repurchasing $450M in Q2 2026 against 99.0M diluted shares at FY2025 end.
Diluted share count is projected to contract from 99.0M to 89.9M by FY2030, boosting consensus diluted EPS from $19.86 in FY2026 to $22.85 in FY2027 and $29.44 by FY2030.
The transition toward automated underwriting facilities like Gemini, which programmatically takes up to 16% of program risk, reduces transactional placement costs, enhances risk selection, and guarantees placement capacity for commercial clients across changing market environments.
Commercial P&C Pricing Cycle Softening
negative
Moderating commercial property and casualty pricing across international lines outside North American casualty creates top-line ad valorem commission drag for global commercial brokerage practices.
Accumulates additional shares on broad market volatility or cyclical insurance rate noise, well below conservative owner earnings power.
Post-Q3 2026 earnings confirmation
Deploy final 25% tranche
Completes full target allocation upon reported verification of mid-single-digit organic growth and tangible Propel margin realization milestones.
USD 500.00+
Harvest remaining position as market prices in full realization of the 30% margin transformation
Scrutinize Propel restructuring cost realization and assess potential thesis demotion.
Share Repurchase Execution
Full-year share repurchases <$750M without accretive M&A deployment
Question capital allocation discipline and lower per-share compounding assumptions.
